Improved methods of bone regeneration are needed in the craniofacial rehabilitation of patients with significant bone deficits secondary to tumor resection, congenital deformities, and prior to prosthetic dental reconstruction. In this study, a gene-enhanced tissue-engineering approach was used to assess bone regenerative capacity of Sonic hedgehog (Shh)-transduced gingival fibroblasts, mesenchymal stem cells, and fat-derived cells delivered to rabbit cranial bone defects in an alginate/collagen matrix. Human Shh cDNA isolated from fetal lung tissue was cloned into the replicationincompetent retroviral expression vector LNCX, in which the murine leukemia virus retroviral LTR drives expression of the neomycin-resistance gene. The rat b-actin enhancer/ promoter complex was engineered to drive expression of Shh. Reverse transcriptase-polymerase chain reaction analysis demonstrated that the transduced primary rabbit cell populations expressed Shh RNA. Shh protein secretion was confirmed by enzyme-linked immunosorbent assay (ELISA). Alginate/ type I collagen constructs containing 2 Â 10 6 Shhtransduced cells were introduced into male New Zealand White rabbit calvarial defects (8 mm) . A total of eight groups (N ¼ 6) were examined: unrestored empty defects, matrix alone, matrix plus the three cell populations transduced with both control and Shh expression vectors. The bone regenerative capacity of Shh gene enhanced cells was assessed grossly, radiographically and histologically at 6 and 12 weeks postimplantation. After 6 weeks, new full thickness bone was seen emanating directly from the alginate/collagen matrix in the Shh-transduced groups. Quantitative twodimensional digital analysis of histological sections confirmed statistically significant (Po0.05) amounts of bone regeneration in all three Shh-enhanced groups compared to controls. Necropsy failed to demonstrate any evidence of treatmentrelated side effects. This is the first study to demonstrate that
Introduction
Indications for bone grafting in dental and craniofacial reconstruction include bone augmentation prior to prosthetic reconstruction, fracture repair, and repair of facial bone defects secondary to trauma, tumor resection, and congenital deformities. The ideal graft material provides a source of cells capable of forming bone when suitably induced, provides the appropriate signals to induce bone formation (an osteoinductive environment), and provides a scaffold for new bone formation (an osteoconductive environment).
Gene-based therapies involve delivering a specific gene to target tissue with the goal of changing the phenotype or protein expression profile of the recipient cell. Our goal was to employ a gene-enhanced tissueengineering approach to develop a bone grafting material that would prove effective at regenerating both small and large osseous defects of the craniofacial region. The ultimate goal of gene-enhanced tissue engineering is to recapitulate the stages of bone regeneration to produce bone that is indistinguishable from normal host bone.
The regulation of bone metabolism is mediated by both systemic and local factors. 1 Of these, the bone morphogenetic proteins (BMPs) and Sonic hedgehog (Shh) appear to be key regulators involved in the formation of new bone, both embryologically and in the repair of fractures.
BMPs are a family of morphogens that regulate bone formation and promote fracture healing, in part by stimulating the differentiation of noncommitted precursor cells into osteoblasts. 2 Studies involving the use of exogenously administered recombinant BMP-2 and BMP-7 to induce bone regeneration have generally been promising in lower animals. [3] [4] [5] A number of recent articles have reviewed the potential for BMP delivery in human bone regeneration. [6] [7] [8] Shh, a 45 kDa vertebrate homolog of the Drosophila segment polarity gene (hedgehog) and a member of the Hedgehog gene family (Sonic, Desert, and Indian hedgehog), is a key protein involved in craniofacial morphogenesis. Shh causes differentiation of pluripotent mesenchymal stem cells into the osteoblastic lineage by upregulating BMPs via Smad signaling. 9 Shh also induces cell proliferation in a tissue-specific manner during embryogenesis via the regulation of epithelialmesenchymal interactions (eg hair follicles 10 and teeth 11, 12 ). The importance of Shh to craniofacial morphogenesis has been demonstrated in experiments with Shh-null mutant mice in which the first branchial arch, which gives rise to both the mandible and maxilla, fails to form. 13 Moreover, mutations in the human Shh gene have been shown to cause holoprocencephaly, 14 a developmental field defect in which the cerebral hemispheres fail to separate into distinct halves. Associated anomalies include hypotelorism, midline cleft lip/palate, proboscis-like nasal structures, and premaxillary agenesis. Mutations of the Shh gene have been identified in the rare dental anomaly, solitary median maxillary central incisor. 15 Excess Shh leads to a mediolateral widening of the frontonasal process and hypertelorism. 14 Shh increases the commitment of pluripotential mesenchymal cells into the osteoblastic lineage 9, 16 by stimulating the expression of a cascade of downstream genes involved in bone development. [17] [18] [19] Transduction of an Shh-coding adenovirus into mouse embryo induces the ectopic expression of BMP-4, Patched-1, Patched-2, and Gli1. 20 Ectopic bone formation can be induced in athymic mice by transplantation of Shh-transfected chicken fibroblast cells. 16 Implantation of Shh-enhanced chicken embryo-derived dermal fibroblasts into nude mice results in ectopic cartilage and bone formation. 21 However, intramuscular transplantation of Shh protein alone does not induce bone formation. 22 This suggests that either the in vivo half-life of Shh is too short to establish the gradient required of Shh to exert its effect, 23 or that Shh must function in concert with other downstream factors involved in bone regeneration.
Shh induces the expression of multiple BMPs, thus mimicking the complex mixture of BMP heterodimers normally present in developing bone. We expected that the Shh-transduced cells would secrete Shh, resulting in the coordinated downstream expression of multiple bone growth factors implicated in bone repair and regeneration, including the BMPs. Genetic enhancement of cells with Shh should result in better bone repair than methods employing direct protein delivery or genetic enhancement approaches using individual BMPs.
In this study, the Shh gene from human fetal lung tissue was cloned into the replication-incompetent retroviral expression vector series LN. 24 The rat b-actin enhancer/promoter was engineered to drive expression of Shh. In order to identify a cell population having the best osteogenic potential, three different primary cell populations, gingival fibroblasts, fat-derived stem cells, and periosteal-derived cells, were genetically enhanced with the Shh vector. Shh expression was confirmed in transduced cells at the RNA and protein levels by reverse transcriptase-polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA). Cells were introduced into adult (age 6 months, weighing 2.8-3.4 kg) male New Zealand White rabbit calvarial defects using a novel alginate/ type I collagen composite bone graft matrix. A total of eight groups (N ¼ 6) were examined: unrestored empty defects, matrix alone, matrix plus the three cell populations transduced with both control and Shh expression vectors. The bone regenerative capacity of Shh gene-enhanced cells was assessed grossly, radiographically and histologically at 6 and 12 weeks postimplantation.
Results

Cloning of human Shh cDNA
We used human fetal lung tissue as the source of total RNA for cDNA cloning of Shh by RT-PCR, 25 since Shh is highly expressed in developing lung. Owing to the high GC content of the Shh cDNA, it was not possible to isolate an undeleted Shh cDNA as a single contiguous fragment. Instead, the Shh cDNA was assembled using conventional molecular biology techniques from five smaller fragments. In one particularly unstable GC-rich section of the Shh gene, silent mutations were incorporated into the nucleotide sequence to reduce the GC content without altering the amino-acid sequence (see Table 1 ). With this exception, DNA sequencing of the entire Shh 5 0 untranslated region and coding sequence confirmed the reported human Shh sequence. 26 
Retroviral vector plasmid and particle generation
Shh cDNA was cloned into the retroviral expression vector LNCX, based on the LN series of vectors in which the murine leukemia virus retroviral LTR drives expression of the neomycin-resistance gene. 24 In the retroviral vector plasmid pLNB-Shh, the Shh cDNA was cloned as a HindIII/ClaI fragment replacing the BMP-7 HindIII/ ClaI fragment in plasmid pLNB-BMP-7 ( Figure 1 ). The b-actin enhancer/promoter was chosen for driving expression of Shh because it is a weaker 'housekeeping' enhancer/promoter than the strong viral cytomegalovirus (CMV) enhancer/promoter, which can result in harmful overexpression of potent cytokines and morphogens. 27 We had previously noted that overexpression of BMP-7 under control of the CMV promoter was toxic to our peristeal-derived cells. 27 Thus, we performed limited dosing experiments by testing strong and weak enhancer/promoters to drive transgenes in primary mesenchymal stem cells and other cells in vitro. We found that the b-actin enhancer/promoter is preferred due to its reasonable expression levels with resultant lack of toxicity.
RT-PCR analysis of Shh expression in the selected primary cell populations
Variations in the signaling range of Shh appear to be due to tissue-specific differences in intracellular processing and tissue-restricted expression of binding proteins. Consequently, three cell types, all of which are in Sonic hedgehog gene-enhanced tissue engineering PC Edwards et al plentiful supply and easily harvested, were analyzed: gingival fibroblasts, fat-derived stem cells, and periosteal-derived cells. Shh RNA expression was confirmed in the three transduced cell lines by RT-PCR using vector-specific primers. Our results (Figure 2) showed that the LNB-Shh-transduced periosteal cells expressed Shh at the RNA level, while control-transduced cells did not. The gingival fibroblasts and fat-derived cells gave similar results. Controls included GAPDH for RNA integrity and reverse transcription positive controls, and no template as negative control.
Shh protein production in transduced cells as assessed by ELISA Cells were grown in T-75 flasks to confluence at a concentration of 1-4 Â 10 6 total cells. A 48 h low serum conditioned media was harvested from the three cell lines (gingival fibroblasts, periosteal, and fat-derived stem cells) carrying the LNCX or LNB-Shh constructs. Indirect ELISAs were performed using a goat IgG antimouse Shh amino-terminal peptide primary antibody, followed by color development using a biotinylated secondary antibody (mouse anti-goat IgG biotinylated antibody and horseradish peroxidase conjugate). Background levels in the control-transduced cells were subtracted out to arrive at the final value. Silent mutations (capital letters) were created in the Shh coding sequence of primers NS189 and NS190, which were annealed together to generate a 91 bp fragment. The mutations were needed to reduce the GC content of this region of Shh, which was unstable in the constructs. All other primers were used in RT-PCR to generate the PCR fragment lengths indicated. (4) GAPDH control for RNA integrity, LNB-Shh-transduced cells, using GAPDH-specific primers NS159 and NS160. The expected 294 bp GAPDH PCR product was generated. (5) GAPDH control for RNA integrity, LNCX-control-transduced cells, using GAPDH-specific primers NS159 and NS160. The expected 294 bp GAPDH PCR product was generated. (6) 6 cells/24 h. This is comparable to the level of BMP production previously observed in osteochondral defect studies using LNB-BMP-7-transduced periosteal-derived cells. 28 
Assembly of alginate/type I collagen/cell composites and assessment of in vitro viability
The matrix is a critical component of any tissueengineering protocol involving anchorage-dependent cells. Several different materials and various combinations of materials were assessed for use as a matrix prior to selection of the alginate/type I collagen mixture. Matrigel (BD Biosciences, Franklin Lakes, NJ, USA), gelatin, agar, Gelfoam (Johnson and Johnson, Summerville, NJ, USA), and BioOss (Luitpold Pharmaceuticals, Shirley, NY, USA) all gave inferior handling and cell compatibility properties. Consequently, we developed a novel alginate/type I bovine collagen-based matrix in which the alginate provides a structural mesh around the cells and the collagen supplies the desired osteoconductive properties to the graft.
Alginate is a biodegradable polysaccharide composed of mannuronic and guluronic acid units. The porous nature of alginate gels allows for the migration of cells and regulatory proteins inside the network. 29 The alginate used in these studies was from Macrocystitis pyrifera (kelp) with a medium viscosity and is composed of 61% mannuronic and 39% guluronic acid and a molecular weight of B100 000 Da. Type I collagen (1%) was added to increase the osteoconductive potential of the alginate. 30 Although our experimental protocol did not require culturing of transfected cells in the graft material prior to implant into the defects, it was necessary to first assess the viability of cells in this composite bone graft material. Consequently, composites of alginate/type I collagen/ periosteal-derived cells were prepared and submitted for histological sectioning immediately after assembly (time 0) and after 7 days in culture. It was noted that the cells were evenly distributed throughout the graft material at time 0 (Figure 3a) . After 1 week in culture, the cells were healthy and had expanded in clusters throughout the graft (Figure 3b ), demonstrating the suitability of this graft material.
Bone regeneration at 6 and 12 weeks
Adult male (age 6 months) New Zealand White rabbits were used for the in vivo assessment of bone regeneration. Full thickness 8 mm cranial bone defects (frontal and parietal bones, four defects per rabbit) were created using a trephine bur. The surgically created defects were restored with the selected transduced cells or the corresponding controls in the alginate/type 1 collagen matrix. Dosing was accomplished at the cell number level, not at the promoter level. In all, 2 Â 10 6 cells were implanted per defect. The experimental groups comprised allogenic gingival fibroblasts, periosteal and fat-derived stem cells transduced with the replicationincompetent Shh retroviral vector (LNB-Shh) and control vector (LNCX). Additional controls included alginate/ collagen matrix alone and empty defects. A total of 12 calvarial defects (six per time/group) were analyzed for each experimental group. After 6 or 12 weeks, the animals were killed and post-mortem radiographs were taken. Figure 4 is representative of the radiographic results seen at 6 weeks for all cell types. Empty defects, matrix alone, and control-transduced cells show minimal levels of bone regeneration. Conversely, Shh-transduced cells show very substantial levels of bone regeneration radiographically.
The defect sites were identified visually and submitted for histologic examination. Composite photomicrographs were assembled from histological sections that were taken through the center of the defects. Only a thin layer of fibrous connective tissue formed in the unrestored empty defect group (Figure 5a ). Matrix alone (without cells) integrated into the defects, but again there was only minimal bone formation (Figure 5b) . However, in all matrix-containing groups, the thickness of the defect space was effectively preserved. The defects restored Conversely, Shh gene enhancement of the periostealderived cells resulted in the formation of new bone, primarily along the edges of the defect (Figure 5d ). This new bone was composed of thin trabeculae, and had a somewhat delicate appearance. The Shh-enhanced fatderived stem cells appeared to form relatively thick trabeculae of bone, but this new bone was not always well dispersed throughout the defect (Figure 5e ). Even Figure 4 Radiographic analysis of calvarial bone regeneration at 6 weeks. Full thickness 8 mm cranial bone defects (frontal and parietal bones, four defects per rabbit) were created in adult male New Zealand White rabbits using a trephine bur. The surgically created defects were restored with the selected transduced cells or the corresponding controls in an alginate/type 1 collagen matrix. Dosing was accomplished at the cell number level (2 Â 10 6 cells per defect). The experimental groups comprised allogenic gingival fibroblasts, periosteal and fat-derived stem cells transduced with the replication-incompetent Shh retroviral vector (LNB-Shh) and control vector (LNCX). Additional controls included alginate/collagen matrix alone and empty defects. After 6 weeks, the animals were killed and postmortem radiographs were taken. Six calvarial defects were analyzed for each experimental group. As demonstrated in this sample radiograph, significantly more bone regeneration is evident in the Shh-enhanced gingival fibroblasts (upper right) compared to the three controls. Figure 5 Histologic assessment of bone regeneration at 6 weeks. At 6 weeks post defect restoration, the animals were killed. The defect sites were identified visually and submitted for histologic examination. Six calvarial defects were analyzed for each experimental group. After decalcification for 3 days, the tissue was embedded in paraffin and 4 mm sections closest to the center of the defect, showing the full diameter of the defects, were cut and stained with hematoxylin and eosin. Composite photomicrographs were assembled from these histological sections. Sonic hedgehog gene-enhanced tissue engineering PC Edwards et al dispersal of new bone was complicated by the observation that the use of fat-derived stem cells often resulted in growth of cyst-like structures in both the controltransduced and gene-enhanced groups. These cyst-like structures were not seen with periosteal-derived cells or gingival fibroblasts.
The best-dispersed bone was seen with the Shhtransduced gingival fibroblasts, where a substantial amount of new bone formation was noted throughout the matrix (Figure 5f ). Equally significant was the thickness of this new bone. On high-power histologic examination, the new bone was shown to be emanating directly from the matrix (Figure 6 ).
Results at 12 weeks (Figure 7a-f) were similar to the findings at 6 weeks. Consistent with the 6-week data, the best-dispersed bone at 12 weeks was seen with the Shhenhanced gingival fibroblasts, where near full thickness bone formation was observed throughout the defect. At higher magnification, significant new bone formation and bone marrow was evident (Figure 8) . In areas where new bone formation was not complete, the remaining matrix had a lower density of cells, indicating that inclusion of more cells in the implants may prove beneficial.
Quantitative digital analysis of histological sections was performed and the total two-dimensional amount of new bone was determined. Briefly, digitized composite Figure 6 Histologic assessment of bone regeneration in Shh gene-enhanced gingival fibroblasts at 6 weeks. This close up photomicrograph demonstrates significant new bone formation at 6 weeks in the defects restored with Shh-gene-enhanced gingival fibroblasts in our alginate/type I collagen matrix (2 Â 10 6 cells per 8 mm calvarial defect). The amorphous, purple material represents remaining matrix. Hematoxylin and eosin stain. Original magnification Â 40. Figure 7 Histologic assessment of bone regeneration at 12 weeks. After 12 weeks, the animals were killed. The defect sites were identified visually and submitted for histologic examination. Six calvarial defects were analyzed for each experimental group. After decalcification for 3 days, the tissue was embedded in paraffin, and 4 mm sections closest to the center of the defect, showing the full diameter of the defects, were cut and stained with hematoxylin and eosin. Composite photomicrographs were assembled from these histological sections. 
Sonic hedgehog gene-enhanced tissue engineering
PC Edwards et al photomicrographs were analyzed on an IBM PC running Windows 98 with Adobe Photoshop 6.0. The mineralized area of the defects in the digitized radiographs was identified by the value of the pixel in the image. The percentage of area of mineralized tissue within the defect size was determined. One-way analysis of variance (ANOVA) was followed by pairwise comparison. A comparison of bone regeneration at 6 and 12 weeks showed statistically significant new bone formation in all three Shh-enhanced cell lines at both time points compared to controls (Figure 9 ).
Finally, regarding the safety of stably transducing cells to express Shh in vivo, autopsies performed on Shhtransduced rabbits failed to demonstrate any evidence of treatment-related side effects after 12 weeks.
Discussion
The adult rabbit calvarial 'critical size defect' model was chosen because the cranial bones, like the maxilla and mandible, are formed through intramembranous ossification. 31, 32 This model has been extensively investigated and characterized with regards to its intrinsic bone healing capacity. 34 While it has been reported 33 that allogeneic cell-mediated femoral bone regeneration in the rat model requires immune suppression, we have not observed tissue rejection-related problems using a rabbit calvarial defect model. It may be that the allogenic cells from different New Zealand White rabbits are not as antigenically heterogenous as the cells from the two different rat strains employed by Lou and co-workers 33 Alternatively, the rabbit calvarial site might be immune privileged.
Based on the early work of Frame, 34 a critical size calvarial defect (CSD; defined as a defect that will not heal completely during the lifespan of the animal) in the adult rabbit was determined to be 15 mm in diameter, when examined 24 weeks postsurgery. However, the concept of CSD is in flux. Since most studies are of limited duration and do not extend over the life of the animal, the CSD is now being redefined as the size of the defect that does not heal over the length of the study. 35 Previous definitions of CSD were based on a twodimensional, linear measurement of bone formation, and did not take into account the overall thickness of the new bone. Consequently, cranial defects that developed a continuous, even if very thin, shelf of bone over the surgical site were considered healed. However, the most important parameter of success in bone healing is the total three-dimensional amount of new bone deposited in the defect, because the goal in most craniofacial applications of bone regeneration is to restore the site to its original three-dimensional state. Therefore, an 8 mm defect size was chosen since there is ample evidence 36 to suggest that this sized defect does not heal spontaneously over a 12-week period.
Our results clearly demonstrate that minimal bone regeneration occurred in empty 8 mm defects, which validates this size defect for study of bone regeneration at time points up to 12 weeks.
Control-transduced cells were used as the best control group for these studies. Control-transduced cells were genetically enhanced with the neomycin-resistance gene and selected in G418. Shh-transduced cells were treated identically as control cells, with the exception that the vector they were transduced with contained the Shh gene driven from the b-actin promoter in addition to the neomycin-resistance gene. We chose not to use nontransduced cells as a control because in previous experiments in which nontransduced cells were used, there was no statistical difference in bone regeneration between the control-transduced and nontransduced groups. 37 Consequently, the control-transduced cells serve as the most suitable control for these studies. Bone regeneration in calvarial defects at 6 and 12 weeks. Histologic slides, obtained from defect sites at 6 and 12 weeks, were digitized and the total two-dimensional amount of new bone in the surgically created defects was quantitated. Briefly, digitized composite photomicrographs were analyzed on an IBM PC running Windows 98 with Adobe Photoshop 6.0. The mineralized area of the defects in the digitized radiographs was identified by the value of the pixel in the image. The percentage of area of mineralized tissue within the defect size was determined. Data was analyzed using ANOVA followed by pairwise comparison. A 'P'-value of less than 0.05 was considered statistically significant. In all cases, Shh gene enhancement of cells resulted in statistically significant differences (Po0.05) compared to controls.
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The matrix is a critical component of any tissueengineering protocol involving anchorage-dependent cells. Ideally, the matrix should be easy to handle, allow for adherence of cells, and provide a three-dimensional scaffold of sufficient strength to hold the defect space. It must also be porous enough to allow for the free diffusion of cells and growth factors. Purified bovine collagen is biocompatible, and because it promotes the mineralization process, it is also osteoconductive. However, we found that a collagen-based system alone did not afford a matrix with the requisite strength to hold the defect space. Moreover, collagen gels tend to contract and lose their shape and consistency after as little as 12 h in culture. 38 Alginate hydrogels are used extensively in cell encapsulation and tissue-engineering applications 39 because of their structural properties and good biocompatibility. 40 The porous nature of alginate gels allows for the migration of cells and cytokines inside the network. Bone marrow stromal cells embedded in alginate alone have been used to regenerate rabbit osteochondral defects 38 and sheep cranial defects, 41 with no evidence of a host immune response. While alginate gels alone support cell proliferation, proliferation can be enhanced by the addition of an osteoconductive material to the matrix. 42 Our results demonstrate improved bone regeneration through the use of a novel alginate/type I bovine collagen-based matrix in which the alginate provides a structural mesh around the cells and the collagen supplies the desired osteoconductive properties to the graft.
Variations in the signaling range of Shh appear to be due to tissue-specific differences in intracellular processing and tissue-restricted expression of binding proteins. This suggests that the ability of cells to respond to Shh may be dependent on the stage of differentiation of the particular cell, with only immature pluripotential cells being capable of differentiating into an osteoblastic lineage. 9 Consequently, three cell types originating from different tissues were analyzed: gingival fibroblasts, fatderived stem cells and periosteal-derived cells. All of these cell types are in plentiful supply and easily harvested. Gingival fibroblasts can be induced to express an osteoblastic phenotype 43, 44 Tissue obtained by liposuction contains a fibroblast cell-like population (fatderived stem cells) that can be induced to differentiate into bone when placed in an appropriate medium. 45 Periosteal-derived cells were selected because of their proven ability to repair bone defects when transfected with BMP-expressing retroviral vectors. 27 In this study, our objective was to determine if Shh genetic enhancement using the identical vector system would improve bone regenerative capacity of the chosen cell types over control-transduced cells. Therefore, no attempt was made to control the level of Shh expressed from the different cell types, as promoters operate at unpredictable levels in different cell types. Dosing was accomplished at the cell number level, not at the promoter level.
The selection of the number of cells implanted per defect (2 Â 10 6 cells) was based on the dose-response curves of Gysin et al, 46 who demonstrated that the optimum cell count for an 8 mm calvarial defect was 1-2 Â 10 6 BMP-expressing cells. Additionally, our in vitro experiments (Figure 3a and b) established that a density of 2 Â 10 6 cells/450 ml of construct afforded an acceptable cell density at the histologic level. However, our in vivo results suggest that this total cell count may be insufficient for complete bone regeneration at 12 weeks. In some areas where new bone formation was not complete, the remaining matrix had a lower density of cells. Increasing the concentration of cells should result in faster and more complete bone regeneration.
The use of gene-enhanced tissue engineering may overcome limitations associated with the one-time delivery of a bolus of protein by providing a sustained, local delivery of protein factors. In this study, a replication-incompetent retroviral expression vector based on the LN series 24 was used. In this vector, the relatively weak rat b-actin enhancer/promoter was used to drive expression of Shh. Overexpression of potent morphogens under control of the stronger CMV enhancer/promoter or from other transient expression systems that grossly overexpress transgenes can be toxic. 27 The retroviral vectors used in this study were engineered for sustained local delivery of physiologic levels of the expressed gene. In prior studies, 27 we reported that expression of BMP-7 in periosteal-derived cells transduced with similar retroviral vectors was measurable for several weeks prior to loss of expression.
Other systems could have been used which result in local presence of supraphysiologic levels of protein for relatively short periods of time, but this would not have mimicked what occurs during the normal course of early skeletogenesis; a process we are trying to emulate. Although a retroviral vector system was used in this study, other gene delivery systems with greater clinical applicability for bone regeneration that do not require ex vivo cell culture and that result in sustained presence of physiological levels of transgene expression could also be used in future studies.
We demonstrated that Shh delivery to bone defects, in this case through a novel gene-enhanced tissue-engineering approach, resulted in significant bone regeneration. It is interesting to note that all three cell types, selected for use in these studies because of their reported bone regenerative capacity, were capable of regenerating bone but only when genetically enhanced with Shh. In addition, although the Shh-gene-enhanced fat-derived stem cells proved capable of regenerating bone, the unexpected formation of cyst-like structures observed with the use of these cells requires further study to determine impact on long-term bone regeneration.
Our ELISA data support the hypothesis that only low levels of transgene expression are needed to heal cranial defects; the level of expression being only one component of a cell's ability to stimulate bone regeneration. It is our contention, and that of others, 17, 23 that a gradient of secreted morphogen is needed for optimal bone regeneration. There are different ways to try to attain such a gradient in vivo. The retroviral system employed in this study allows for the secretion of modest amounts of morphogen over an extended period of time, which results in the build up of efficacious morphogen levels locally.
It was not determined in this study whether the transduced cells are differentiating into osteoblasts or instead are triggering other uncommitted mesenchymal cells that have migrated into the defect site to differentiate into osteoblasts, although the former is suspected.
In the future, in situ hybridization experiments will be performed to determine whether the bone cells in the regenerated grafts contain the vector, indicating transdifferentiation into bone as found in our earlier osteochondrat tissue regeneration studies. 37 In conclusion, this is the first study to demonstrate that Shh delivery to bone defects, in this case through a novel gene-enhanced tissue-engineering approach, results in significant bone regeneration. This encourages further development of the Shh-mediated tissue-engineering approach for bone regeneration.
Materials and methods
Approval of experimental protocols
The protocol was approved by the North Shore-Long Island Jewish Health System Institutional Biosafety Committee. Animal protocols were approved by the North Shore-Long Island Jewish Health System Institutional Animal Care and Use Committee.
Isolation and culture of primary cell populations Rabbit periosteal-derived cells. Rabbit periosteum was harvested from the anteromedial surface of the proximal tibia of male New Zealand White rabbits. A rectangular incision was made to expose the bone and periosteum was separated from underlying bone. Only the cambium layer was harvested (confirmed by histological observation). Harvested periosteum was diced into 1 mm cubes and cultured in SDMEM media (composed of high glucose DMEM supplemented with 10% heat-inactivated fetal bovine serum, 1 Â antibiotic/ antimycotic, 12 mM HEPES, 0.4 mM L-proline, and 50 mg/L ascorbic acid).
Fat-derived stem cells. Fat tissue was harvested from the inguinal and abdominal regions of male New Zealand White rabbits. The tissue was placed in SDMEM and digested with 0.075% collagenase/DNAse mixture at 371C in a 5% CO 2 incubator for 1 h. The cell suspension was then filtered through a 100 nm NYTEC filter, the cells centrifuged, washed twice, and cultured in SDMEM.
Gingival fibroblasts. Gingival tissue was harvested from the palate of male New Zealand White rabbits. The tissue was cut into 1 mm explants and cultured in SDMEM at 371C in humidified 5% CO 2 .
Construction of retroviral expression vectors
The Shh cDNA, isolated from human fetal lung tissue, had previously been cloned into the retroviral expression vector LNCX, based on the LN series of vectors in which the murine leukemia virus retroviral LTR drives expression of the neomycin-resistance gene. 24 In the retroviral vector plasmid pLNB-Shh, the Shh cDNA was cloned as a HindIII/ClaI fragment replacing the BMP-7 HindIII/ ClaI fragment in plasmid pLNB-BMP-7. The rat b-actin enhancer/promoter, a relatively weak housekeeping promoter with low-level constitutive expression, was chosen to drive expression of Shh because expression of potent morphogens from this promoter is not toxic to cells. The retroviral vector plasmids were CaPO 4 transfected into GP+E 86 cells. 47 Retroviral vector particle containing conditioned media was collected 48 h posttransfection and used to transduce PA317 cells in the presence of 8 mg/ml polybrene. 48 PA317 cells were selected for 10-12 days in D10 medium supplemented with 300 mg/ml active neomycin analog G418. Amphotropic retroviral vector particles were collected from a cloned producer cell line having a titer of B1 Â 10 6 Neo CFU/ml.
Transduction and selection of cells
Cells were transduced at B25% confluence in six-well dishes using 400 ml of retroviral vector particles and 1.6 ml D10 supplemented with 8 mg/ml polybrene. Two separate transductions were performed on consecutive days. Kill control experiments determined that the 10 day selective conditions for rabbit periosteal-derived cells, fat-derived stem cells, and gingival fibroblasts are 600, 1800, and 900 mg/ml active G418, respectively. Populations of resultant G418 selected rabbit cells were used in all studies.
RT-PCR analysis of Shh expression
Total RNA was isolated from B1 Â 10 6 transduced cells using the RNeasy kit (Qiagen). First strand synthesis was performed using the Reverse Transcription System (Promega). Shh RT-PCR was performed using Herculase Hot Start Enhanced DNA Polymerase (Stratagene) as follows: annealing temperature 601C; 30 s to anneal; 721C extension temperature; 2 min to extend; 30 cycles. Oligonucleotide PCR primers NS145 5 0 aaaaagcttgggcga gatgctgctgctggcgagatgtct 3 0 (forward primer in 5 0 coding sequence of Shh) and NS239 5 0 ccctttttctggagactaaa taaaatc 3 0 (reverse primer downstream of the Shh gene in the viral vector) were used to amplify a 1446 bp vector-specific Shh transcript encompassing the 5 0 end of human Shh and flanking vector sequence encoded specifically by LNB-Shh.
GAPDH primers NS159 (5 0 ggtcatccctgagctgaacg 3 0 ) and NS160 (5 0 ttcgttgtcataccaggaaat 3 0 ), at an annealing temperature of 551C (30 s to anneal; 721C extension temperature, 1 min to extend; 30 cycles), were used to generate an expected 294 bp GAPDH transcript as control of RNA quality. A no template control was also included.
ELISA of Shh secretion by transduced cells
Cells were grown to confluence in SDMEM supplemented with G418 at a concentration of 1-4 Â 10 6 total cells. A 48-72-h conditioned, low serum media (Optimem; Gibco) was harvested from the three cell lines (gingival fibroblasts, periosteal and fat-derived stem cells) carrying the LNCX or LNB-Shh constructs. Indirect ELISAs were performed by adding 100 ml of conditioned media into 96-well flat-bottom Maxisorp plates (Nunc, Roskilido, Denmark). All assays were performed in triplicate. Antigen was bound at 371C for 1 h, blocked with 200 ml PBS-T (Phosphate Buffered Saline with 0.1% Tween-20) for 1 h at room temperature, and then washed three times with PBS-T. The primary antibody, goat IgG antimouse Shh amino-terminal peptide (100 mg/ml; R&D Systems; Minneapolis, MN, USA), was diluted 1:100 in PBS-T, and 100 ml was added per well for 2 h at room temperature. This antibody cross reacts with human Shh. Three washes with PBS-T were followed by development using a biotinylated secondary antibody Sonic hedgehog gene-enhanced tissue engineering PC Edwards et al (mouse anti-goat IgG biotinylated antibody; Vectastain ABC kit, Vector Laboratories; Burlingame, CA, USA) and horseradish peroxidase conjugate (Vectastain ABC kit). The chromogenic substrate tetramethylbenzidine (TMB Microwell Peroxidase Substrate; KPL, Gaithersberg, MD, USA) was used for color development. The plates were read at OD450 using a model 400 ATC ELISA plate reader (SLT Lab Instruments; Grodig, Austria). Unconditioned Optimem was used as background control. The background reactivity present in the control-transduced cell lines was subtracted from the raw values to arrive at a final determination of Shh protein production in the transduced cell lines (ng Shh/1 Â 10 6 total cells/24 h).
Assembly of gene-modified cell-alginate-collagen matrix constructs
A solution of purified type 1 bovine collagen (Vitrogen 100, 3.1 mg/ml collagen; Cohesion, Palo Alto, CA, USA) was prepared by adding 800 ml of Vitrogen 100 to 100 ml of 10 Â PBS, followed by the addition of 100 ml of 0.1 m NaOH.
The gene-modified cell lines were trypsinized and the cell pellets, each containing 2.0 Â 10 6 cells, were resuspended in a 50 ml Falcon tube (Becton Dickinson; Lincoln Park, NJ, USA) in 200 ml of 2.0% alginic acid (sodium salt, medium viscosity, from Macrocystis pyrifera; Sigma, St Louis, MO, USA). The cell-alginate solution was added to 200 ml of the above-prepared type 1 collagen preparation. Initial gelation was accomplished by placing the cell-alginate-collagen amalgam at 371C for 30 min. Gelation of the alginate was completed by adding 4 ml of 100 mM CaCl 2 directly to the amalgam. The matrix was allowed to gel for 15 min and then rinsed three times with PBS prior to implantation.
Surgical procedures
A total of 24 adult male (age 6 months) New Zealand White rabbits, weighing 3.0-4.0 kg, were used in this study. The rabbits were kept in standard laboratory double cages with a 12-h day/night cycle and an ambient temperature of 211C. The rabbits were permitted 2 h free housing per day, and had access to tap water and food pellets.
Food and water were withheld from the rabbits for 6 and 1 h, respectively prior to surgery. A total of 0.4cc/ 3 kg of Tazidine was administered 18 h prior to surgery by means of intramuscular injection, Animals were preanaesthetised with an intramuscular injection of 5 mg/kg acepromazine, and induced with 12.5 mg/kg ketamine and 4% Isoflurane. Adequateness of anaesthesia was assessed by the absence of withdrawal reflex to toe pinch and the absence of corneal reflex.
In each animal, the surgical field was shaved and prepped with iodophor. Following the infiltration of local anaesthesia (2% lidocaine with 1:100 000 epinephrine), midline sagittal incisions were extended from the occipital region to the bridge of the nose. Subperiosteal dissections were performed anteriorly and posteriorly to expose the frontal and parietal regions of the cranium. Using a trephine bur with saline irrigation, four full thickness 8 mm bone defects were created. The surgically created defects were restored with the selected transduced cells in the alginate matrix or the corresponding controls. The scalp tissues were reapproximated to the remaining calvarium, and sutured with 4-0 Vicryl sutures. Postoperative analgesia was accomplished by administering 0.1 mg/kg Buprenex subcutaneously q12 h for the first 48 h.
After 6 or 12 weeks, the animals were anesthetized with ketamine and killed by means of a pentobarbital overdose.
Experimental groups
The experimental groups comprised allogenic gingival fibroblasts, periosteal and fat-derived stem cells transduced with the replication-incompetent Shh retroviral vector (LNB-Shh) and control vector (LNCX). Additional controls included alginate/collagen matrix alone and empty defects, for a total of eight groups. Four full thickness 8 mm bone defects were created per animal. The different groups were evenly distributed between the animals and between anterior vs posterior calvarial sites. In total, 12 calvarial defects (six per time/group) were analyzed for each experimental group.
Radiographic analysis of bone defect healing
Post-mortem radiographs (Kodak Ultraspeed DF-50 Dental Film) were taken of the sectioned calvaria using a portable X-ray unit (Philips Dens-o-Matic, 65 kVp, 7.5 mAmp, 1.5 s).
Histological analysis
The defect sites were identified visually, and then sectioned into halves. One half was decalcified in 'overnight bone decalcification' solution (Decal Corporation, Tallman, NY, USA) for 3 days. After embedding in paraffin, 4 mm sections closest to the center of the defect, showing the full diameter of the defects, were obtained and stained with hematoxylin and eosin. When processing the alginate/collagen/cell matrices for histologic examination, 10 mm CaCl 2 was added to the formalin during the initial fixation period to prevent depolymerization of the alginate matrix. The matrices were then fixed overnight with 50 mm BaCl 2 at 41C to permanently crosslink the alginate prior to final processing.
Quantitative digital analysis of histological sections was performed. Digitized composite photomicrographs were analyzed on an IBM PC running Windows 98 with Adobe Photoshop 6.0. The mineralized area of the defects in the digitized radiographs was identified by the value of the pixel in the image. The percentage of area of mineralized tissue within the defect size was determined.
Statistical analysis
Determination of n (the minimum sample size to provide proper discriminatory capability) for in vivo animal studies was carried out by power analysis. A sample size of six would yield 80% power to detect a difference of 10% between the two groups (case vs control) using a two-tailed, paired t-test with a 0.05 significance level. ANOVA was followed by pairwise comparison. A 'P'-value of less than 0.05 was considered statistically significant.
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